In support of the importance of estimation of serum visfatin for AF patients, Szymanska et al. [41] detected significantly higher plasma visfatin levels in AF patients who were diagnosed with obstructive sleep apnea and apnea severity was correlated with visfatin serum level and recommended considering visfatin as a predictor for AF-associated complications. The gene discussed is NAMPT; the disease is Apnea.